PATENT CLAIM ANALYSIS

Application Number: 15899706
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "249000"]

Abstract:
Provided herein are methods for treating or preventing a solid tumor, non-Hodgkin lymphoma or multiple myeloma in a patient, comprising administering an effective amount of a TOR kinase inhibitor to a patient having a solid tumor, non-Hodgkin lymphoma or multiple myeloma.

Claim (Index 18):
The method of  claim 15 , wherein the solid tumor is an advanced solid tumor.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 88.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13654441', '15277285', '13773686', '14055995', '14835817']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.852179080297402
- 35 USC 102 Novelty (BERT): 0.6114545088511087
- Combined Prediction Score: 0.8281066231527727
- Mean Citation Score: 555.2043679999998
- Max Citation Score: 693.03076
- Similarity Product: 465.65974222078086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test